- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:46 | HLTH Europe 2026: enriching the patient journey with health technologies | ||
| 13:46 | Moderna's mRNA flu vaccine passes FDA AdCom, review underway | ||
| 12:46 | Moderna's mRNA flu vaccine set for FDA review after positive AdCom | ||
| 11:46 | Sun Pharma to acquire Innovcare Lifesciences for $28.7m | ||
| 10:46 | Japan approves Sanofi's Sarclisa combo for MM treatment | ||
| Fr | Biopharma industry confidence at highest in years despite geopolitical headwinds | ||
| Fr | Voro and Alloy partner on tumour-selective TCE therapeutics | ||
| Fr | Biogen to acquire RayThera for up to $1bn | ||
| Do | UniQure to seek approval of Huntington's gene therapy after FDA U-turn | ||
| Do | Jazz and AbCellera sign deal for T-cell engagers in solid tumours | ||
| Do | LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs | ||
| Mi | Biopharma bounces back as M&A impetus fuels recovery | ||
| Mi | Vedana debuts with $46m to progress migraine therapies | ||
| Mi | AviadoBio broadens vMiX gene silencing licence with King's College London | ||
| Mi | Altaris to acquire Simulations Plus in $375m all-cash deal | ||
| Mi | Zai Lab's zocilurtatug pelitecan secures EMA orphan drug status | ||
| Di | HLTH Europe 2026: obesity drugs shift the paradigm, but systemic implementation lags | ||
| Di | Cystic Fibrosis Foundation backs Israeli biotech with $13m to develop inhaled drug | ||
| Di | FDA and MHRA forge new regulatory collaboration initiative | ||
| Di | Alkermes' alixorexton secures FDA and EC orphan designations | ||
| Di | ALK's EURneffy secures MHRA approval for anaphylaxis treatment | ||
| 15.06. | Younger UK children to benefit from new dose of nasal spray allergy drug | ||
| 15.06. | FDA oncology roundup: drugs, imaging agents and diagnostics gain approval | ||
| 15.06. | Simcere and Stanford partner to develop IPF therapies | ||
| 15.06. | FDA clears MSD's Keytruda combo plus Welireg for ccRCC treatment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.